AZ chief: Emerging markets are tougher than you think

AstraZeneca ($AZN) CEO David Brennan (photo) talks emerging markets, external collaborations and townhall meetings in a Q&A with Roger Crockett. And, extending the current prefence for bolt-on M&A, Brennan reminds us that he's "not a fan" of megamergers. Report